Impact of Microbial Metabolites on Microbiota–Gut–Brain Axis in Inflammatory Bowel Disease
Open Access
- 4 February 2021
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (4), 1623
- https://doi.org/10.3390/ijms22041623
Abstract
The complex bidirectional communication system existing between the gastrointestinal tract and the brain initially termed the “gut–brain axis” and renamed the “microbiota–gut–brain axis”, considering the pivotal role of gut microbiota in sustaining local and systemic homeostasis, has a fundamental role in the pathogenesis of Inflammatory Bowel Disease (IBD). The integration of signals deriving from the host neuronal, immune, and endocrine systems with signals deriving from the microbiota may influence the development of the local inflammatory injury and impacts also more distal brain regions, underlying the psychophysiological vulnerability of IBD patients. Mood disorders and increased response to stress are frequently associated with IBD and may affect the disease recurrence and severity, thus requiring an appropriate therapeutic approach in addition to conventional anti-inflammatory treatments. This review highlights the more recent evidence suggesting that alterations of the microbiota–gut–brain bidirectional communication axis may concur to IBD pathogenesis and sustain the development of both local and CNS symptoms. The participation of the main microbial-derived metabolites, also defined as “postbiotics”, such as bile acids, short-chain fatty acids, and tryptophan metabolites in the development of IBD-associated gut and brain dysfunction will be discussed. The last section covers a critical evaluation of the main clinical evidence pointing to the microbiome-based therapeutic approaches for the treatment of IBD-related gastrointestinal and neuropsychiatric symptoms.This publication has 371 references indexed in Scilit:
- Cerebral Low-Molecular Metabolites Influenced by Intestinal Microbiota: A Pilot StudyFrontiers in Systems Neuroscience, 2013
- Impaired butyrate oxidation in ulcerative colitis is due to decreased butyrate uptake and a defect in the oxidation pathway*Inflammatory Bowel Diseases, 2012
- MyD88 signalling in colonic mononuclear phagocytes drives colitis in IL-10-deficient miceNature Communications, 2012
- Invasive potential of gut mucosa-derived fusobacterium nucleatum positively correlates with IBD status of the hostInflammatory Bowel Diseases, 2011
- Lactobacillus bulgaricus OLL1181 activates the aryl hydrocarbon receptor pathway and inhibits colitisImmunology & Cell Biology, 2011
- Highlighting new phylogenetic specificities of Crohnʼs disease microbiotaInflammatory Bowel Diseases, 2011
- A Pathobiont of the Microbiota Balances Host Colonization and Intestinal InflammationCell Host & Microbe, 2010
- Visceral Pain: The Neurophysiological MechanismPublished by Springer Science and Business Media LLC ,2009
- Pain and inflammatory bowel diseaseInflammatory Bowel Diseases, 2009
- Communicable Ulcerative Colitis Induced by T-bet Deficiency in the Innate Immune SystemCell, 2007